Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus
Authors:
Open Access
- 1 March 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (3) , 844-849
Abstract
Background: Oral lichen planus (OLP) is a potentially malignant disorder associated with an increased risk for oral cancer. The purpose of this study was to determine protein expression of podoplanin and ATP-binding cassette, G2 subfamily (ABCG2) in patients with OLP and evaluate their use as biomarkers for OLP malignant transformation risk.Keywords
This publication has 28 references indexed in Scilit:
- Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of managementOral Oncology, 2009
- Histological and Culture Studies with Respect to ABCG2 Expression Support the Existence of a Cancer Cell Hierarchy in Human Hepatocellular CarcinomaThe American Journal of Pathology, 2007
- Identification of Cancer Stem Cell–Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell LineCancer Research, 2007
- Overexpression of podoplanin in oral cancer and its association with poor clinical outcomeCancer, 2006
- Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like propertiesHepatology, 2006
- ABCG2 Expression Is an Independent Unfavorable Prognostic Factor in Esophageal Squamous Cell CarcinomaOncology, 2006
- Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomasInternational Journal of Cancer, 2004
- Observer variability in the histologic assessment of oral premalignant lesionsJournal of Oral Pathology & Medicine, 1995
- Malignant development of lichen planus‐affected oral mucosaJournal of Oral Pathology & Medicine, 1988
- Malignant potential of oral lichen planus: observations in 722 patients from IndiaJournal of Oral Pathology & Medicine, 1986